Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curie Bio is a specialized venture capital firm and therapeutics accelerator designed to help drug hunters build and launch biotech companies. The firm provides seed-stage funding alongside a sophisticated operational platform that includes drug discovery services, a network of contract research organizations, and strategic mentorship. By acting as a hands-on co-founder, Curie Bio aims to reduce the friction of company creation and accelerate the path from initial discovery to Series A financing. The Curie Bio Seed Fund I is the firm's inaugural vehicle dedicated to advancing early-stage therapeutic programs across a wide range of modalities and disease areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curie Bio Seed Fund I.